Keio University reports up to four years of follow-up on four patients given iPS-derived cells for spinal cord injury: no tumors, no serious harm. What it means, and how Japan's path compares to the US and Europe.
FANUC, Yaskawa and Kawasaki are teaming up with Fujitsu and NVIDIA to bring Physical AI to factories, warehouses and hospitals. What each firm is really after, how they plan to bridge simulation and real machines, and whether Japan can keep its lead against US and Chinese humanoid makers.
Kuroda Precision holds about 30% of the global market for EV drive motor-core dies. The 100-year-old firm now bets on amorphous alloy and cobalt-heavy permendur, and on a supply chain shaped by geopolitics.
Purupuru Maker, a free browser tool that wobbles only the parts of an image you paint, has gone viral in Japan and abroad. Meet the solo developer behind it and Japan's culture of gloriously pointless web toys.
Kushiro Airport in Hokkaido is the first in Japan to fully deploy WOLF-GUARD, a self-driving version of the famous Monster Wolf robot. In trials, the Monster Wolf cut small-animal intrusions by about 60 percent. Here's how the red-eyed, howling patroller works, and how it compares with the falcons, border collies and radar used at airports abroad.
Why does osteosarcoma cluster in the knees of growing teenagers? A University of Tokyo team, working from an accidental clue in aging research, has pieced together how the cancer starts: an accelerator gene (c-Myc), a brake gene (p53), and a signal from the bone's growth plate. It could reshape drug discovery for a rare cancer.
A century-old Japanese packaging company will launch a flexible CIGS solar cell in early 2027, betting that proven, long-life thin-film tech can beat still-maturing perovskite to Japan's weak roofs and walls. The contrarian logic, and the catches.
Researchers at Showa and Kansai Medical Universities grew mesothelial-like cells from human iPS cells to repair the peritoneum, the membrane that wears out and ends peritoneal dialysis. A look at the mouse proof-of-concept and why Japan's PD rate is so unusually low.
NYK Line, Japan's largest shipping company, is working with Mitsubishi Heavy Industries to catch reusable rocket boosters on a ship at sea. The idea began in an in-house training program, became the first shipping-company project selected for JAXA's Space Strategy Fund, and now faces a question NYK's own engineers raise: will anyone launch often enough to make it pay?
Bridgestone's airless AirFree tire is now in permanent service on an autonomous shuttle in Higashiomi, Shiga, a national first. How its puncture-proof resin-spoke design works, why driverless and MaaS fleets need it, how it contrasts with Michelin's Uptis strategy, and whether it's really Moon-bound.
Japan's iPS cell therapy already treated fresh spinal injuries. Now a Keio University team is preparing a trial for the far harder chronic phase, where more than 100,000 patients have long been told regeneration simply isn't possible.